In the development of diabetic nephropathy, with the assistance of IGF2BP2, METTL3-mediated M6A modification of TIMP2 is involved in inflammatory damage in podocytes by regulating Notch signaling [36]. Here, TIMP2 is linked to diabetic kidney disease.